Gilead Sciences
GILD
#118
Rank
A$252.13 B
Marketcap
A$203.34
Share price
-2.14%
Change (1 day)
18.20%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2026 (TTM): A$11.09

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is A$10.36. In 2025 the company made an earnings per share (EPS) of A$9.56 an increase over its 2024 EPS that were of A$0.53.

EPS history for Gilead Sciences from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$11.0916%
2025A$9.561702.63%
2024A$0.53-91.65%
2023A$6.3523.98%
2022A$5.12-25.86%
2021A$6.914850%
2020A$0.14-97.64%
2019A$5.920.9%
2018A$5.8718.71%
2017A$4.94-64.88%
2016A$14.07-18.45%
2015A$17.2555.28%
2014A$11.11296.02%
2013A$2.8117.89%
2012A$2.38

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$12.19 17.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$1.83-82.35%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$2.87-72.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$39.40 280.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$20.21 95.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$13.05 26.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$7.72-25.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$23.74 129.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$4.99-51.82%๐Ÿ‡บ๐Ÿ‡ธ USA